US FDA nod for Sagent Pharma's Heparin sodium injection USP
Tuesday, July 06, 2010 09:00 IST Schaumburg, Illinois
Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, announced that the US Food and Drug Administration (FDA), has approved the company’s nine presentations of heparin sodium injection, USP.